SCHEMBL368609

SCHEMBL368609

CCCCCNc1c(-c2ccccc2)cccc1C(C)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 11/20 0.43
SOAT1 P35610 2/20 0.42
FAAH O00519 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15519628 1.00 PTGS2 (0.43) PTGS2SOAT1FAAH
SCHEMBL11467737 0.79 CXCL8 (0.49)
SCHEMBL341491 0.79 SOAT1 (0.46) SOAT1
SCHEMBL338541 0.78 MAPT (0.43) PTGS2SOAT1
SCHEMBL339362 0.76 CXCL8 (0.46) PTGS2
SCHEMBL1926388 0.76 KCNA3 (0.48) SOAT1
SCHEMBL27782837 0.75 PTGER1 (0.49) SOAT1
SCHEMBL341017 0.75 KMT2A (0.45) PTGS2
SCHEMBL4785901 0.73 BCAT2 (0.51) SOAT1
SCHEMBL2393839 0.73 PTGS2 (0.56) PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3359522-B1 PROCESS FOR PREPARATION OF N-BOC BIPHENYL ALANINOL CHIRAL QUEST SUZHOU CO LTD (CN) 2020-02-26 EP disclosed
US-10183909-B2 Process for preparation of N-Boc biphenyl alaninol CHIRAL QUEST (SUZHOU) CO., LTD. (CN) 2019-01-22 US disclosed
US-20180297941-A1 PROCESS FOR PREPARATION OF N-BOC BIPHENYL ALANINOL CHIRAL QUEST (SUZHOU) CO., LTD. (CN) 2018-10-18 US disclosed
EP-2890672-B1 PROCESSES FOR PREPARING INTERMEDIATES FOR THE MANUFACTURE OF NEP INHIBITORS NOVARTIS AG (CH) 2018-05-30 EP disclosed
US-9624163-B2 Process for preparing intermediates useful in the manufacture of NEP inhibitors NOVARTIS AG (CH) 2017-04-18 US disclosed
WO-2017059759-A1 PROCESS FOR PREPARATION OF N-BOC BIPHENYL ALANINOL CHIRAL QUEST (SUZHOU) CO., LTD. (CN) 2017-04-13 WO disclosed
US-9181175-B2 Process for manufacture and resolution of 2-acylamino-3-diphenylpropanoic acid Zhejiang Jiuzhous Pharmaceutical Co., Ltd. (CN) 2015-11-10 US disclosed
US-20150210632-A1 NEW PROCESS NOVARTIS AG (CH) 2015-07-30 US disclosed
EP-2890672-A1 NEW PROCESS Novartis AG (CH) 2015-07-08 EP disclosed
EP-2387558-B1 PROCESS FOR MANUFACTURE AND RESOLUTION OF 2-ACYLAMINO-3-DIPHENYLPROPANOIC ACID ZHEJIANG JIUZHOU PHARM CO LTD (CN) 2014-08-27 EP disclosed
US-20140179947-A1 PROCESS FOR MANUFACTURE AND RESOLUTION OF 2-ACYLAMINO-3-DIPHENYLPROPANOIC ACID ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD. (CN) 2014-06-26 US disclosed
US-8703990-B2 Process for manufacture and resolution of 2-acylamino-3-diphenylpropanoic acid Zhejiang Jiuzhous Pharmaceutical Co., Ltd. (CN) 2014-04-22 US disclosed
WO-2014032627-A1 NEW PROCESS ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD (CN) 2014-03-06 WO disclosed
US-20120016151-A1 PROCESS FOR MANUFACTURE AND RESOLUTION OF 2-ACYLAMINO-3-DIPHENYLPROPANOIC ACID NOVARTIS AG (CH) 2012-01-19 US disclosed
EP-2387558-A1 PROCESS FOR MANUFACTURE AND RESOLUTION OF 2-ACYLAMINO-3-DIPHENYLPROPANOIC ACID Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (CN) 2011-11-23 EP disclosed
US-20110253230-A1 Temperature Sensitive Valve Having Shape Memory Actuator OMNITEK PARTNERS LLC (US) 2011-10-20 US disclosed
WO-2010081410-A1 PROCESS FOR MANUFACTURE AND RESOLUTION OF 2-ACYLAMINO-3-DIPHENYLPROPANOIC ACID ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD. (CN) 2010-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150210632-A1 NEW PROCESS MME, DNPEP, ACE PTGS2 2089/4885SOAT1 2398/4885FAAH 61/4885
US-20140179947-A1 PROCESS FOR MANUFACTURE AND RESOLUTION OF 2-ACYLAMINO-3-DIPHENYLPROPANOIC ACID DNPEP, MME, DPP7 PTGS2 1756/4885SOAT1 1675/4885FAAH 127/4885
US-20120016151-A1 PROCESS FOR MANUFACTURE AND RESOLUTION OF 2-ACYLAMINO-3-DIPHENYLPROPANOIC ACID DNPEP, MME, DPP7 PTGS2 1756/4885SOAT1 1675/4885FAAH 127/4885
US-10183909-B2 Process for preparation of N-Boc biphenyl alaninol RABL6, PF4, SPIN4 PTGS2 3766/4885SOAT1 3126/4885FAAH 991/4885
US-20180297941-A1 PROCESS FOR PREPARATION OF N-BOC BIPHENYL ALANINOL RABL6, DBF4, SPIN4 PTGS2 3760/4885SOAT1 3126/4885FAAH 974/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.